(NASDAQ: MTEM) Molecular Templates's forecast annual revenue growth rate of -47.2% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Molecular Templates's revenue in 2024 is $57,306,000.On average, 1 Wall Street analysts forecast MTEM's revenue for 2024 to be $32,245,608, with the lowest MTEM revenue forecast at $32,245,608, and the highest MTEM revenue forecast at $32,245,608. On average, 1 Wall Street analysts forecast MTEM's revenue for 2025 to be $33,857,888, with the lowest MTEM revenue forecast at $33,857,888, and the highest MTEM revenue forecast at $33,857,888.
In 2026, MTEM is forecast to generate $47,293,558 in revenue, with the lowest revenue forecast at $47,293,558 and the highest revenue forecast at $47,293,558.